{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:47:16Z","timestamp":1784774836716,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["2022HXMY4P \\u2014 CUP D53D23010340006"],"award-info":[{"award-number":["2022HXMY4P \\u2014 CUP D53D23010340006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117983","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T06:58:11Z","timestamp":1752821891000},"page":"117983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis, and biological activity of 2-aroylbenzofuran-3-ols and 2-aroylbenzofuran derivatives: A new route towards hMAO-B inhibition"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-6925","authenticated-orcid":false,"given":"Paolo","family":"Guglielmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Coluccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guya Diletta","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ortuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Pizzicannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arrighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Salvitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Secci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Diomede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117983_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2023.104736","article-title":"A critical analysis of national dementia care guidances","volume":"130","author":"Vinay","year":"2023","journal-title":"Health Policy"},{"key":"10.1016\/j.ejmech.2025.117983_bib2","article-title":"Relationship of curcumin with aging and alzheimer and parkinson disease, the Most prevalent age-related neurodegenerative diseases: a narrative review","author":"Turer","year":"2024","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejmech.2025.117983_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.765584","article-title":"Reducing the risk of cognitive decline and dementia: WHO recommendations","volume":"12","author":"Chowdhary","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejmech.2025.117983_bib4","first-page":"877","article-title":"Vital role of monoamine oxidases and cholinesterases in central nervous System drug research: a sharp dissection of the pathophysiology, comb chem high throughput","volume":"23","author":"Aksoz","year":"2020","journal-title":"Screen"},{"key":"10.1016\/j.ejmech.2025.117983_bib5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117983_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153730","article-title":"Evaluation of the common molecular basis in alzheimer's and parkinson's diseases","volume":"20","author":"Rana","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117983_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101957","article-title":"The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders","volume":"114","author":"Jones","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.ejmech.2025.117983_bib8","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.2174\/0929867328666210203204710","article-title":"Monoamine Oxidase-B (MAO-B) inhibitors in the treatment of alzheimer's and Parkinson's disease","volume":"28","author":"\u00d6zdemir","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib9","series-title":"Membrane Protein Complexes: Structure and Function","first-page":"117","article-title":"Monoamine oxidases","author":"Edmondson","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117983_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00702-018-1915-z","article-title":"The structure of monoamine oxidases: past, present, and future","volume":"125","author":"Iacovino","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117983_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/BMC.2011.030","article-title":"Structures and mechanism of the monoamine oxidase family","volume":"2","author":"Gaweska","year":"2011","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ejmech.2025.117983_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-018-1861-9","article-title":"Kinetics, mechanism, and inhibition of monoamine oxidase","volume":"125","author":"Ramsay","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117983_bib13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","article-title":"90 years of monoamine oxidase: some progress and some confusion","volume":"125","author":"Tipton","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117983_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105831","article-title":"Monoamine oxidase and neurodegeneration: mechanisms, inhibitors and natural compounds for therapeutic intervention","volume":"179","author":"Banerjee","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2025.117983_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101256","article-title":"Monoamine oxidases in age-associated diseases: new perspectives for old enzymes","volume":"66","author":"Santin","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117983_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111516","article-title":"Sex-dependent monoamine oxidase isoforms expression patterns during human brain ageing","volume":"197","author":"Sanfilippo","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2025.117983_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/B:NEAB.0000018736.84877.4f","article-title":"The age dynamics of monoamine oxidase activity and levels of lipid peroxidation products in the human brain","volume":"34","author":"Volchegorskii","year":"2004","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.ejmech.2025.117983_bib18","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2174\/156802612805219950","article-title":"Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival","volume":"12","author":"Naoi","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0924-977X(98)00035-2","article-title":"MAO inhibitors and oxidant stress in aging brain tissue","volume":"9","author":"Alper","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2025.117983_bib20","series-title":"Molecular Mechanism of the Relation of Monoamine Oxidase B and its Inhibitors to Parkinson's Disease: Possible Implications of Glial Cells","author":"Nagatsu","year":"2006"},{"key":"10.1016\/j.ejmech.2025.117983_bib21","author":"Meiser"},{"key":"10.1016\/j.ejmech.2025.117983_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/pr.59.2.1","article-title":"Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase","volume":"59","author":"Marchitti","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117983_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105461","article-title":"Review on the interactions between dopamine metabolites and \u03b1-Synuclein in causing Parkinson's disease","volume":"162","author":"Sivakumar","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2025.117983_bib24","first-page":"7479","article-title":"Monoamine oxidase-B inhibition facilitates \u03b1-synuclein secretion in vitro and delays its aggregation in rAAV-based rat models of Parkinson's disease","volume":"41","author":"Nakamura","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117983_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00702-019-02106-9","article-title":"The catecholaldehyde hypothesis: where MAO fits","volume":"127","author":"Goldstein","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117983_bib26","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M608126200","article-title":"Effect of 4-hydroxy-2-nonenal modification on \u03b1-synuclein aggregation","volume":"282","author":"Qin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbadis.2015.01.015","article-title":"On the role of 4-hydroxynonenal in health and disease","volume":"1852","author":"Csala","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2025.117983_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00215","article-title":"The association of iron and the pathologies of Parkinson's diseases in MPTP\/MPP+-induced neuronal degeneration in non-human primates and in cell culture","volume":"11","author":"Shi","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2025.117983_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/brain\/awt291","article-title":"Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons","volume":"137","author":"Neuhaus","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2025.117983_bib30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3109\/10715762.2012.662277","article-title":"Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin","volume":"46","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejmech.2025.117983_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/0929867327666200121165931","article-title":"New aspects of monoamine oxidase B inhibitors: the key role of halogens to open the golden door","volume":"28","author":"Mathew","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/17460441.2019.1637415","article-title":"Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?","volume":"14","author":"Guglielmi","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117983_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1871524915666150831141705","article-title":"Opening new scenarios for human MAO inhibitors","volume":"16","author":"Monte","year":"2016","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00702-022-02465-w","article-title":"A critical appraisal of MAO-B inhibitors in the treatment of Parkinson's disease","volume":"129","author":"Jost","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117983_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine Oxidase-B inhibitors for the treatment of parkinson's disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejmech.2025.117983_bib36","article-title":"Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: a systematic review","volume":"8","author":"Tsuboi","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejmech.2025.117983_bib37","series-title":"Int Rev Neurobiol","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-386467-3.00009-1","article-title":"Selective inhibitors of monoamine oxidase type B and the \u201ccheese effect,\u201d","author":"Finberg","year":"2011"},{"key":"10.1016\/j.ejmech.2025.117983_bib38","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1080\/14756366.2019.1653864","article-title":"Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity","volume":"34","author":"Guglielmi","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib39","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1021\/acs.jmedchem.1c00510","article-title":"Mapping Chromone-3-Phenylcarboxamide pharmacophore: quid est veritas?","volume":"64","author":"Mesiti","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114507","article-title":"Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties","volume":"239","author":"Reis","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112650","article-title":"Chalcones: unearthing their therapeutic possibility as monoamine oxidase B inhibitors","volume":"205","author":"Guglielmi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28124814","article-title":"Structure-Based design of novel MAO-B inhibitors: a review","volume":"28","author":"Mateev","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117983_bib43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/adsc.201000256","article-title":"Microwave-assisted Dieckmann reaction: efficient one-step synthesis of 2-aroylbenzofuran-3-ols","volume":"352","author":"Zhou","year":"2010","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117983_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104238","article-title":"Potent \u03b1-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: syntheses, in vitro, kinetics, and in silico studies","volume":"104","author":"Ali","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib45","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/acs.jmedchem.4c00045","article-title":"Dual inhibitors of brain carbonic anhydrases and monoamine Oxidase-B efficiently protect against Amyloid-\u03b2-Induced neuronal toxicity, oxidative stress, and mitochondrial dysfunction","volume":"67","author":"Giovannuzzi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115091","article-title":"8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin\u2019s antidepressant profile: synthesis, biological evaluation and docking studies","volume":"248","author":"Matos","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib47","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2174\/0929867321666131218094352","article-title":"Metabolism of selegiline [(-)-Deprenyl)]","volume":"21","author":"Kalasz","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib48","author":"Hernandez-Baltazar"},{"key":"10.1016\/j.ejmech.2025.117983_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-Hydroxydopamine model of parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2025.117983_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-5793(04)00209-1","article-title":"Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane","author":"Binda","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2025.117983_bib51","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117983_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117983_bib53","author":"Lipinski"},{"key":"10.1016\/j.ejmech.2025.117983_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117983_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(24)00476-9","article-title":"Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease","author":"Pedder","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.117983_bib56","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2025.117983_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejmech.2025.117983_bib58","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2025.117983_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020150","article-title":"Involvement of astrocytes in the Formation, maintenance, and function of the blood\u2013brain barrier","volume":"13","author":"Schiera","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117983_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05025-y","article-title":"Role of pericytes in blood\u2013brain barrier preservation during ischemia through tunneling nanotubes","volume":"13","author":"Pisani","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117983_bib61","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117983_bib62","series-title":"P-Glycoprotein, a Gatekeeper in the blood-brain Barrier","author":"Schinkel","year":"1999"},{"key":"10.1016\/j.ejmech.2025.117983_bib63","series-title":"Schr\u00f6dinger Release 2020-4: Maestro","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117983_bib64","series-title":"Schr\u00f6dinger Release 2020-4: Ligprep","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117983_bib65","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pka and protonation State prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.117983_bib66","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib67","author":"Berman"},{"key":"10.1016\/j.ejmech.2025.117983_bib68","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1021\/acs.jmedchem.8b00357","article-title":"Tight-binding inhibition of human monoamine oxidase B by chromone analogs: a kinetic, crystallographic, and biological analysis","volume":"61","author":"Reis","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein data bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117983_bib70","series-title":"Schr\u00f6dinger Release 2020-4: Protein Preparation Wizard","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117983_bib71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcc.20222","article-title":"Importance of accurate charges in molecular docking: Quantum Mechanical\/Molecular Mechanical (QM\/MM) approach","volume":"26","author":"Cho","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib72","series-title":"Schr\u00f6dinger Release 2020-4: Glide","year":"2020"},{"key":"10.1016\/j.ejmech.2025.117983_bib73","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117983_bib74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jcc.540110405","article-title":"Macromodel\u2014An integrated software system for modeling organic and bioorganic molecules using molecular mechanics","volume":"11","author":"Mohamadi","year":"1990","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117983_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.676512","article-title":"Transforming growth Factor-Beta1 and human gingival fibroblast-to-myofibroblast differentiation: molecular and morphological modifications","volume":"12","author":"Marconi","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2025.117983_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24102005","article-title":"The up-regulation of oxidative stress as a potential mechanism of novel MAO-B inhibitors for glioblastoma treatment","volume":"24","author":"Marconi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117983_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020386","article-title":"The beneficial effect of carvacrol in HL-1 cardiomyocytes treated with LPS-G: Anti-inflammatory pathway investigations","volume":"11","author":"Marconi","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.117983_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24213948","article-title":"Kinesin Eg5 targeting inhibitors as a new strategy for gastric adenocarcinoma treatment","volume":"24","author":"Marconi","year":"2019","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425007482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:56:25Z","timestamp":1776920185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425007482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":78,"alternative-id":["S0223523425007482"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117983","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological activity of 2-aroylbenzofuran-3-ols and 2-aroylbenzofuran derivatives: A new route towards hMAO-B inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117983"}}